Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling
- PMID: 23497505
- PMCID: PMC3672803
- DOI: 10.1186/bcr3396
Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling
Abstract
Introduction: Although oestrogen is essential for the development of the normal breast, adult mammary stem cells are known to be oestrogen receptor alpha (ER) negative and rely on paracrine signals in the mammary epithelium for mediation of developmental cues. However, little is known about how systemic oestrogen regulates breast cancer stem cell (CSC) activity.
Methods: Here, we tested the effects of oestrogen on CSC activity in vitro and in vivo and investigated which paracrine signalling pathways locally mediate oestrogen effects.
Results: CSC-enriched populations (ESA+CD44+CD24low) sorted from ER positive patient derived and established cell lines have low or absent ER expression. However, oestrogen stimulated CSC activity demonstrated by increased mammosphere and holoclone formation in vitro and tumour formation in vivo. This effect was abrogated by the anti-oestrogen tamoxifen or ER siRNA. These data suggest that the oestrogen response is mediated through paracrine signalling from non-CSCs to CSCs. We have, therefore, investigated both epidermal growth factor (EGF) and Notch receptor signals downstream of oestrogen. We demonstrate that gefitinib (epidermal growth factor receptor (EGFR) inhibitor) and gamma secretase inhibitors (Notch inhibitor) block oestrogen-induced CSC activity in vitro and in vivo but GSIs more efficiently reduce CSC frequency.
Conclusions: These data establish that EGF and Notch receptor signalling pathways operate downstream of oestrogen in the regulation of ER negative CSCs.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3672803/bin/bcr3396-1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3672803/bin/bcr3396-2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3672803/bin/bcr3396-3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3672803/bin/bcr3396-4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3672803/bin/bcr3396-5.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3672803/bin/bcr3396-6.gif)
Similar articles
-
Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.Cancer Res. 2016 Jun 1;76(11):3156-65. doi: 10.1158/0008-5472.CAN-15-2528. Epub 2016 Apr 6. Cancer Res. 2016. PMID: 27197152 Free PMC article.
-
Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.Oncotarget. 2015 Nov 10;6(35):37526-43. doi: 10.18632/oncotarget.6063. Oncotarget. 2015. PMID: 26462028 Free PMC article.
-
Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.Neoplasia. 2015 Jun;17(6):497-508. doi: 10.1016/j.neo.2015.06.001. Neoplasia. 2015. PMID: 26152358 Free PMC article.
-
Mammary stem cells and breast cancer--role of Notch signalling.Stem Cell Rev. 2007 Jun;3(2):169-75. doi: 10.1007/s12015-007-0023-5. Stem Cell Rev. 2007. PMID: 17873349 Review.
-
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S99-S111. doi: 10.1677/erc.1.01005. Endocr Relat Cancer. 2005. PMID: 16113104 Review.
Cited by
-
Leptin: A Heavyweight Player in Obesity-Related Cancers.Biomolecules. 2023 Jul 6;13(7):1084. doi: 10.3390/biom13071084. Biomolecules. 2023. PMID: 37509120 Free PMC article. Review.
-
Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens.Front Oncol. 2023 Jul 10;13:1199105. doi: 10.3389/fonc.2023.1199105. eCollection 2023. Front Oncol. 2023. PMID: 37492478 Free PMC article. Review.
-
The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness.Front Endocrinol (Lausanne). 2023 Feb 23;14:1083048. doi: 10.3389/fendo.2023.1083048. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36909339 Free PMC article. Review.
-
Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors.Breast Cancer Res. 2022 Dec 8;24(1):88. doi: 10.1186/s13058-022-01585-1. Breast Cancer Res. 2022. PMID: 36482488 Free PMC article.
-
Research progress in breast cancer stem cells: characterization and future perspectives.Am J Cancer Res. 2022 Jul 15;12(7):3208-3222. eCollection 2022. Am J Cancer Res. 2022. PMID: 35968346 Free PMC article. Review.
References
-
- Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, Eaves CJ. Purification and unique properties of mammary epithelial stem cells. Nature. 2006;439:993–997. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous